Quality control of pharmaceuticals with NIR: From lab to process line

This work describes a general framework for assessing the active pharmaceutical ingredient (API) and excipient concentrations simultaneously in pharmaceutical dosage forms based on laboratory-scale measurements. The work explores the comprehensive development of a near infrared (NIR) analytical protocol for the quantification of the API and excipients of a pharmaceutical formulation. The samples were based on a paracetamol (API) formulation with three excipients: microcrystalline cellulose, talc, and magnesium stearate. The developed method was based on laboratory-scale samples as calibration samples and pilot-scale samples (powders and tablets) as model test samples. Both types of samples were produced according to an experimental design. The samples were measured in reflectance mode in a Fourier-transform NIR spectrometer. Additionally, a new method for determining the minimum number of calibration samples was proposed. It was concluded that the use of laboratory-scale samples to construct the calibration set is an effective way to ensure the concentration variability in the development of calibration models for industrial applications. With this method, both API and excipients can be determined in high-throughput applications in the pharmaceutical industry.